Efficacy and Safety of Tralokinumab with Concomitant Topical Corticosteroids in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of the ECZTRA 3 Trial

Main Article Content

Boni E. Elewski
Matthew J. Zirwas
Richard G. Langley
Andrew F. Alexis
Karen A. Veverka
John Zoidis
Azra Kurbasic
Jonathan I. Silverberg


Atopic Dermatitis, Biologic, Topical Steroid, Tralokinumab, Safety, Efficacy


Abstract not available.


1. Weidinger S, Novak N. Lancet 2016; 387: 1109–1122.

2. Silverberg JI et al. Ann Allergy Asthma Immunol 2018; 121: 340–347.

3. Dalgard FJ et al. J Invest Dermatol 2015; 135: 984–991.

4. Bieber T. Allergy 2020; 75: 54–62.

5. Tsoi LC et al. J Invest Dermatol 2019; 139: 1480–1489.

6. Popovic B et al. J Mol Biol 2017; 429: 208–219.

7. Silverberg JI et al. Br J Dermatol 2020; in press.

Most read articles by the same author(s)